Journal article
NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome
American journal of physiology. Lung cellular and molecular physiology, Vol.307(1), pp.L71-L82
07/01/2014
DOI: 10.1152/ajplung.00054.2014
PMCID: PMC4080282
PMID: 24793165
Abstract
Systemic inflammatory response syndrome (SIRS) is a common clinical condition in patients in intensive care units that can lead to complications, including multiple organ dysfunction syndrome (MODS). MODS carries a high mortality rate, and it is unclear why some patients resolve SIRS, whereas others develop MODS. Although oxidant stress has been implicated in the development of MODS, several recent studies have demonstrated a requirement for NADPH oxidase 2 (NOX2)-derived oxidants in limiting inflammation. We recently demonstrated that NOX2 protects against lung injury and mortality in a murine model of SIRS. In the present study, we investigated the role of NOX2-derived oxidants in the progression from SIRS to MODS. Using a murine model of sterile systemic inflammation, we observed significantly greater illness and subacute mortality in gp91(phox-/y) (NOX2-deficient) mice compared with wild-type mice. Cellular analysis revealed continued neutrophil recruitment to the peritoneum and lungs of the NOX2-deficient mice and altered activation states of both neutrophils and macrophages. Histological examination showed multiple organ pathology indicative of MODS in the NOX2-deficient mice, and several inflammatory cytokines were elevated in lungs of the NOX2-deficient mice. Overall, these data suggest that NOX2 function protects against the development of MODS and is required for normal resolution of systemic inflammation.
Details
- Title: Subtitle
- NOX2 protects against progressive lung injury and multiple organ dysfunction syndrome
- Creators
- Laura C Whitmore - Department of Pediatrics, Inflammation Program, the University of Iowa, Iowa City, Iowa; and Interdisciplinary Graduate Program in Molecular and Cellular Biology, the University of Iowa, Iowa City, IowaKelli L Goss - Department of Pediatrics, Inflammation Program, the University of Iowa, Iowa City, Iowa; andElizabeth A Newell - Department of Pediatrics, Inflammation Program, the University of Iowa, Iowa City, Iowa; andBrieanna M Hilkin - Department of Pediatrics, Inflammation Program, the University of Iowa, Iowa City, Iowa; andJessica S Hook - Department of Pediatrics, Inflammation Program, the University of Iowa, Iowa City, Iowa; andJessica G Moreland - Department of Pediatrics, Inflammation Program, the University of Iowa, Iowa City, Iowa; and Interdisciplinary Graduate Program in Molecular and Cellular Biology, the University of Iowa, Iowa City, Iowa jessica.moreland@utsouthwestern.edu
- Resource Type
- Journal article
- Publication Details
- American journal of physiology. Lung cellular and molecular physiology, Vol.307(1), pp.L71-L82
- DOI
- 10.1152/ajplung.00054.2014
- PMID
- 24793165
- PMCID
- PMC4080282
- NLM abbreviation
- Am J Physiol Lung Cell Mol Physiol
- ISSN
- 1040-0605
- eISSN
- 1522-1504
- Publisher
- American Physiological Society; United States
- Grant note
- R01-AI-073872 / NIAID NIH HHS R21 AI109127 / NIAID NIH HHS
- Language
- English
- Date published
- 07/01/2014
- Academic Unit
- Critical Care; Stead Family Department of Pediatrics; Iowa Neuroscience Institute; Internal Medicine
- Record Identifier
- 9984065824902771
Metrics
21 Record Views